We founded the Swiss Startup Group because the wealth of experience we have accumulated over the years is meant to be shared. Check out our news and find extensive background information on investments, startups and the world of VC.
Diabetes is one of the most common diseases of our time and a key driver for the increase in healthcare expenditures in the years to come. The market for diabetes care devices alone is expected to reach over $40 billion by 2025.
The Swiss Startup Group continues to invest in the wearables sector and supports Supersapiens’ continuous glucose monitoring system for sport performance.
With a new title being created every two minutes, the Swiss platform surpasses seven figures of user-generated games.
The ETH spin-off has raised an $18 million (CHF 17 million) Series A to expand its product offerings and international footprint. The round is led by venture capital funds Vorwerk Ventures and Blue Horizon. Additionally, Swiss Nati Goali Yann Sommer and existing investors Stephan Schmidheiny, Good Seed Ventures, the Gaydoul Group, the ETH Zurich Foundation and Joyance Partners are also bringing in new capital.
